Celyad Announces October and November 2019 Investor Conference Schedule

Regulatory News:

Celyad (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD) (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell-based therapies, today announced that management plans to participate at the following investor conferences in October and November 2019.

Conference details:

Investir Day 1^st Edition

Date:

Thursday, October 3, 2019

Presentation time:

12:45 p.m. CEDT

Location:

Paris, France

 

 

CF&B Communication European Large & Midcap Event 19th Edition

Date: October 14-15, 2019 Location: Paris, France  

Bryan, Garnier & Co European Healthcare Conference

Date:

Wednesday, November 13, 2019

Location:

Paris, France

 

 

Finance Avenue 2019

Date:

Saturday, November 16, 2019

Presentation Time:

12:55 p.m. CEDT

Location:

Brussels, Belgium

 

 

Jefferies 2019 London Healthcare Conference

Date:

November 20 - 21, 2019

Location:

London, United Kingdom

 

***END***

About Celyad
Celyad is a clinical-stage biopharmaceutical company focused on the development of specialized CAR-T cell-based product candidates and utilizes its expertise in cell engineering to target cancer. Celyad’s CAR-T cell platform has the potential to treat a broad range of solid and hematologic tumors. The company’s lead clinical candidate, CYAD-01, an autologous NKG2D-based CAR-T therapy, is currently being evaluated in several Phase 1 clinical trials to assess safety and clinical activity for the treatment of hematological malignancies, such as acute myeloid leukemia, and solid cancers, such as metastatic colorectal cancer. Celyad is also developing CYAD-101, an investigational, non-gene edited, allogeneic (donor derived) NKG2D-based CAR-T therapy, which is currently being evaluated in a Phase 1 trial for the treatment of patients with metastatic colorectal cancer. Celyad was founded in 2007 and is based in Mont-Saint-Guibert, Belgium, and New York, NY. Celyad’s ordinary shares are listed on the Euronext Brussels and Euronext Paris exchanges, and its American Depository Shares are listed on the Nasdaq Global Market, all under the ticker symbol CYAD.